In a recent study, Finkelman and colleagues [26] reviewed the evolution of Ki-67 as a biomarker for breast cancer, highlighting its importance in assessing cellular proliferation, prognosis, and chemotherapy response. This evidence concerns the gene MKI67 and breast carcinoma.